Stereotaxis (STXS) Capital Expenditures Growth (5y) (2015 - 2026)
Stereotaxis (STXS) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.93 Bn | 121.71 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.94 Bn | 44.13 Bn | 2.15 Bn |
| 3 | Alcon | 33.13 Bn | 31.47 Bn | 1.53 Bn |
| 4 | Medline | 32.87 Bn | 30.63 Bn | 1.84 Bn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.28 Bn | 22.84 Bn | 329.20 Mn |
| 7 | Solventum | 14.11 Bn | 13.55 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.80 Bn | 13.66 Bn | 735.40 Mn |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn |
| 10 | Stereotaxis | 132.02 Mn | 117.40 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.37% |
| Dec 31, 2024 | -31.90% |
| Sep 30, 2024 | 10.76% |
| Sep 30, 2023 | -45.00% |
| Jun 30, 2023 | -31.64% |
| Mar 31, 2023 | 103.54% |
| Dec 31, 2022 | 107.92% |
| Sep 30, 2022 | 24.77% |
| Mar 31, 2022 | 206.06% |
| Dec 31, 2019 | -29.11% |
| Sep 30, 2019 | -1.59% |
| Dec 31, 2017 | 73.96% |
| Sep 30, 2017 | 31.75% |
| Mar 31, 2017 | -44.59% |
| Dec 31, 2015 | -3.24% |
| Sep 30, 2015 | -33.53% |